ESRX

UnitedHealth Group Inc Stock Is Already Set for a Comeback

UnitedHealth (UNH) stock is down on an Amazon (AMZN) headline. I bet this dip is not the start of something more sinister, so here's how you can catch this proverbial falling knife.

What Remains For Rite Aid Corporation? The Risks of Going It Alone

Rite Aid bulls hope it finds a buyer, while bears see it circling the drain. RAD stock might be fun to trade right now, but watch it closely.

Quant Score Analytics Keep Express Scripts (ESRX) Ratings Upgrade to Hold

Express Scripts Holdings Co (NASDAQ:ESRX) is ranked as a Hold using the methodology of Louis Navellier for investing and his Portfolio Grader stock evaluator. The shares have been upgraded from a Sell to a Hold in the last week.

Lousy Industry Group Rank Keep Express Scripts (ESRX) a Sell

Currently, Express Scripts Holdings Co (NASDAQ:ESRX) has a Sell using Louis Navellier's investing system and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ESRX has had from Portfolio Grader for 11 months.

Adverse Earnings Momentum Make Express Scripts (ESRX) a Sell

Express Scripts Holdings Co (NASDAQ:ESRX) is classified as a component of the 82 company Health Care Providers & Services GICS industry group, which is a segment of the 781 company GICS Health Care sector. The market value of ESRX is $34.7 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader ranking places it 66 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 616 among the 781 companies in the sector, and number 3,779 in the nearly 5,000 company Portfolio Grader universe.

Analysis of Earnings Visibility Keep Express Scripts (ESRX) a Sell

Portfolio Grader currently ranks Express Scripts Holdings Co (NASDAQ:ESRX) a Sell. With proprietary fundamental and quantitative metrics developed by Louis Navellier, this analytical tool evaluates nearly 5,000 stocks weekly. This represents no change from the previous week and is the same ranking ESRX has had from Portfolio Grader for 11 months.

Express Scripts (ESRX) a Sell on Slumping Sales Growth

Express Scripts Holdings Co (NASDAQ:ESRX) is classified as a component of the 82 company Health Care Providers & Services GICS industry group, which is part of the 782 company GICS Health Care sector. ESRX's market value is $34.0 billion which places it in the top decile in its industry group. The stock's Portfolio Grader ranking currently places it 65 among the 82 companies in this industry group, a position that is well below-average; squarely in the bottom quartile of the sector with a ranking of 616 among the 782 companies in the sector, and number 3,803 in the nearly 5,000 company Portfolio Grader universe.

Analytics for Earnings Momentum Keep Express Scripts (ESRX) a Sell

Portfolio Grader currently ranks Express Scripts Holdings Co (NASDAQ:ESRX) a Sell. The system for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking ESRX has had from Portfolio Grader for 11 months.

Express Scripts (ESRX) a Sell on Falling Sales Growth

Express Scripts Holdings Co (NASDAQ:ESRX) is classified as a member of the 82 company Health Care Providers & Services GICS industry group, which is part of the 783 company GICS Health Care sector. ESRX's market value is $35.2 billion which places it in the top decile in its industry group. The ranking for ESRX by Portfolio Grader places it 57 among the 82 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 505 among the 783 companies in the sector, and number 3,369 in the nearly 5,000 company Portfolio Grader universe.

Analytics for Earnings Momentum Keeps Express Scripts (ESRX) a Sell

Currently, Express Scripts Holdings Co (NASDAQ:ESRX) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 11 months.

Express Scripts (ESRX) a Sell on Shrinking Quant Score

Currently, Express Scripts Holdings Co (NASDAQ:ESRX) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 11 months.

Anthem Inc (ANTM), CVS Health Corp (CVS) Team Up in Prescription Drugs Deal

Anthem (ANTM) and CVS Health (CVS) have announced that they are teaming up to create a new pharmacy benefits manager in 2020.

Stock of Express Scripts (ESRX) Ranked a Sell

Express Scripts Holdings Co (NASDAQ:ESRX) is ranked as a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. ESRX has maintained this ranking for 11 months.

Express Scripts Holding Company (ESRX) Buys eviCore Healthcare in $3.6B Deal

Express Scripts (ESRX) has announced that it will be acquiring eviCore Healthcare for $3.6 billion in a deal that will close by 2017's end.

5 Healthcare Stocks to Sell Before They’re Crushed Too Far Down

These five healthcare stocks to sell are getting hammered on news that Amazon is interested in entering the space.

Stock of Express Scripts (ESRX) Ranked a Sell

Express Scripts Holdings Co (NASDAQ:ESRX) is ranked as a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. ESRX has maintained this ranking for 11 months.

Rite Aid Corporation (RAD) Stock Looks Tempting, But It’s Still Trouble

Rite Aid actually looks cheap in some ways, but as profits decline, that advantage will disappear. Don't buy this "bottom" in RAD stock.

7 Explosive Healthcare Stocks to Buy Now

Healthcare has taken a leadership role in the markets again, and these seven healthcare stocks to buy are making a splash right now.

3 Big Stock Charts for Tuesday: Akamai Technologies, Inc. (AKAM), Dollar Tree, Inc. (DLTR) and Express Scripts Holding Company (ESRX)

Shares of Akamai Technologies (AKAM), Dollar Tree (DLTR) and Express Scripts (ESRX) all jumped more than 1% yesterday, but only one of these is flashing a real buy signal.